{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:59:18Z","timestamp":1778039958714,"version":"3.51.4"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T00:00:00Z","timestamp":1372032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065928","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T21:16:51Z","timestamp":1372108611000},"page":"e65928","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Discovery of a Novel Dual Fungal CYP51\/Human 5-Lipoxygenase Inhibitor: Implications for Anti-Fungal Therapy"],"prefix":"10.1371","volume":"8","author":[{"given":"Eric K.","family":"Hoobler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesha","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G. S.","family":"Warrilow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Smyrniotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josie E.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane E.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore R.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.prostaglandins.2007.01.005","article-title":"Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids","volume":"83","author":"P Rubin","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/0003-4819-127-6-199709150-00009","article-title":"Antileukotrienes in the Treatment of Asthma","volume":"127","author":"PM O'Byrne","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-3","article-title":"The Molecular Biology and Regulation of 5-Lipoxygenase","volume":"161","author":"OP R\u00e5dmark","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.bi.63.070194.002123","article-title":"5-Lipoxygenase","volume":"63","author":"AW Ford-Hutchinson","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","article-title":"Therapeutic options for 5-lipoxygenase inhibitors","volume":"112","author":"O Werz","year":"2006","journal-title":"Pharmacology & Therapeutics"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/13543771003602012","article-title":"5-Lipoxygenase inhibitors: a review of recent developments and patents","volume":"20","author":"C Pergola","year":"2010","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081481","article-title":"Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production","volume":"210","author":"C Zouboulis Ch","year":"2005","journal-title":"Dermatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00128071-200001020-00001","article-title":"Management of seborrheic dermatitis and pityriasis versicolor","volume":"1","author":"J Faergemann","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/14656566.8.9.1365","article-title":"A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism","volume":"8","author":"J Faergemann","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"ref10","first-page":"359","article-title":"The role of ketoconazole in seborrheic dermatitis","volume":"80","author":"M Borgers","year":"2007","journal-title":"Cutis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1358\/dot.2008.44.5.1216598","article-title":"Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations","volume":"44","author":"N Scheinfeld","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0006-2952(86)90072-9","article-title":"Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo","volume":"35","author":"JR Beetens","year":"1986","journal-title":"Biochemical Pharmacology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2249.2007.03470.x","article-title":"Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4","volume":"150","author":"HC Steel","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1021\/jm801085s","article-title":"Pirinixic Acid Derivatives as Novel Dual Inhibitors of Microsomal Prostaglandin E2 Synthase-1 and 5-Lipoxygenase","volume":"51","author":"A Koeberle","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0165-6147(92)90100-K","article-title":"Designing therapeutically effective 5-lipoxygenase inhibitors","volume":"13","author":"RM McMillan","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/jm00092a001","article-title":"5-lipoxygenase: properties, pharmocology, and the quinolinyl(bridged)aryl class of inhibitors","volume":"35","author":"JH Musser","year":"1992","journal-title":"J of Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/np900465e","article-title":"Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes","volume":"72","author":"SJ Robinson","year":"2009","journal-title":"Journal of Natural Products"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0006-2952(93)90185-Y","article-title":"Criteria for the identification of non-redox inhibitors of 5-lipoxygenase","volume":"45","author":"JP Falgueyret","year":"1993","journal-title":"Biochemical Pharmacology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0223-5234(99)00225-1","article-title":"Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?","volume":"34","author":"NY Robert","year":"1999","journal-title":"European Journal of Medicinal Chemistry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3565(25)23086-5","article-title":"5-lipoxygenase inhibitory activity of zileuton","volume":"256","author":"GW Carter","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(95)12297-4","article-title":"Zileuton","volume":"348","author":"KA McGill","year":"1996","journal-title":"The Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0192-0561(92)90182-K","article-title":"The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor","volume":"14","author":"RL Bell","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/jm9700474","article-title":"Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors","volume":"40","author":"AO Stewart","year":"1997","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0024-3205(80)90028-4","article-title":"Parallel inhibition of neutrophil arachidonic acid metabolism and lysosomal enzyme secretion by nordihydroguaiaretic acid","volume":"27","author":"RW Walenga","year":"1980","journal-title":"Life Sciences"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1021\/bi00396a031","article-title":"Reductive Inactivation of Soybean Lipoxygenase-1 by Catechols","volume":"26","author":"C Kemal","year":"1987","journal-title":"Biochemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/jm0201262","article-title":"Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase","volume":"45","author":"S Whitman","year":"2002","journal-title":"J Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"17952","DOI":"10.1021\/bi981989t","article-title":"Structural and thermochemical characterization of lipoxygenase-catechol complexes","volume":"37","author":"C Pham","year":"1998","journal-title":"Biochemistry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1021\/bi00182a027","article-title":"Structural Characterization of Alkyl and Peroxyl Radicals in Solutions of Purple Lipoxygenase","volume":"33","author":"MJ Nelson","year":"1994","journal-title":"Biochemistry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/ml100029k","article-title":"The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor","volume":"1","author":"Y Ducharme","year":"2010","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.110.166967","article-title":"Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain","volume":"334","author":"JL Masferrer","journal-title":"J Pharmacol Exp Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/np020462l","article-title":"Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases","volume":"66","author":"T Amagata","year":"2003","journal-title":"J Nat Prod"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1016\/j.bmc.2007.08.015","article-title":"Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries","volume":"15","author":"JD Deschamps","year":"2007","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/j.bmc.2007.07.036","article-title":"Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2","volume":"15","author":"Y Vasquez-Martinez","year":"2007","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1021\/bi0273462","article-title":"Kinetic investigations of the rate-limiting step in human 12- and 15-lipoxygenase","volume":"42","author":"EN Segraves","year":"2003","journal-title":"Biochemistry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/jm1008852","article-title":"Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1","volume":"53","author":"G Rai","year":"2010","journal-title":"J Med Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1021\/jm900945d","article-title":"5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103)","volume":"52","author":"JH Hutchinson","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/1056-8719(92)90002-I","article-title":"A specific asay for lukotriene B4 in human whole blood","volume":"28","author":"J Fogh","year":"1992","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-2952(92)90302-Y","article-title":"Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors","volume":"43","author":"SM Spaethe","year":"1992","journal-title":"Biochemical Pharmacology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1128\/AAC.00587-10","article-title":"Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51)","volume":"54","author":"AG Warrilow","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles","volume":"397","author":"N Strushkevich","year":"2010","journal-title":"J Mol Biol"},{"key":"ref41","first-page":"303","article-title":"The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism","volume":"2","author":"RW Estabrook","year":"1972","journal-title":"Methods Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","article-title":"The Carbon Monoxide-Binding Pigment of Liver Microsomes. Ii. Solubilization, Purification, and Properties","volume":"239","author":"T Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature","volume":"239","author":"T Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/(SICI)1097-0061(19990630)15:9<755::AID-YEA417>3.0.CO;2-8","article-title":"Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents","volume":"15","author":"DC Lamb","year":"1999","journal-title":"Yeast"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bcp.2008.10.012","article-title":"Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase","volume":"77","author":"JD Lutz","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chembiol.2007.10.011","article-title":"Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth","volume":"14","author":"GI Lepesheva","year":"2007","journal-title":"Chem Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.M510317200","article-title":"CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B\u2032 helix defines substrate preferences of sterol 14alpha-demethylase","volume":"281","author":"GI Lepesheva","year":"2006","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1574-6968.1995.tb07797.x","article-title":"Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug","volume":"131","author":"K Venkateswarlu","year":"1995","journal-title":"FEMS Microbiol Lett"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1016\/j.bmcl.2010.09.095","article-title":"Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domain","volume":"20","author":"HY Lo","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.tet.2004.05.096","article-title":"A selective reductive amination of aldehydes by the use of Hantzsch dihydropyridines as reductant","volume":"60","author":"T Itoh","year":"2004","journal-title":"Tetrahedron"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1021\/jo048489s","article-title":"Azulene-Substituted Aromatic Amines. Synthesis and Amphoteric Redox Behavior of N,N-Di(6-azulenyl)-p-toluidine and N,N,N\u2032,N\u2032-Tetra(6-azulenyl)-p-phenylenediamine and Their Derivatives","volume":"70","author":"S Ito","year":"2005","journal-title":"The Journal of Organic Chemistry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/oms.1210020406","article-title":"The structural significance of doubly charged ion spectra. Phenylenediamine derivatives","volume":"2","author":"P Vouros","year":"1969","journal-title":"Organic Mass Spectrometry"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/jo048324j","article-title":"Synthesis and Characterization of p-Phenylenediamine Derivatives Bearing an Electron-Acceptor Unit","volume":"70","author":"H Sakurai","year":"2005","journal-title":"The Journal of Organic Chemistry"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"NC Gilbert","year":"2011","journal-title":"Science"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"RA Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"TA Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/ja983083g","article-title":"Large competitive kinetic isotope effects in human 15-LO catalysis measured by a novel HPLC method","volume":"121","author":"ER Lewis","year":"1999","journal-title":"J Am Chem Soc"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0076-6879(78)52029-6","article-title":"Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy","volume":"52","author":"CR Jefcoate","year":"1978","journal-title":"Methods Enzymol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1021\/bi00836a049","article-title":"Ligand interactions with cytochrome P-450. I. Binding of primary amines","volume":"8","author":"CR Jefcoate","year":"1969","journal-title":"Biochemistry"},{"key":"ref60","first-page":"1","article-title":"Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists","volume":"46","author":"RA Copeland","year":"2005","journal-title":"Methods Biochem Anal"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1021\/jm2005089","article-title":"Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase","volume":"54","author":"V Kenyon","year":"2011","journal-title":"J Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T12:30:17Z","timestamp":1746016217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065928"}},"subtitle":[],"editor":[{"given":"Daotai","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,24]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065928","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,24]]}}}